2011年度哈佛医学院高级访问学者

滨博士是北京大学药学院药事管理与临床药学系副教授；

中国食品药品监管资源配置合理性研究，国家食药总局，07/2017-06/2018，课题负责人

　　 三明市医药卫生体制改革案例研究，R&D-based Pharmaceutical Association Committee (RDPAC), 03/2016-12/2016，课题负责人

　　 中国药品医保支付价政策效果评价及优化研究—从利益相关者的视角，CMB(China Medical Board), 01/2016-12/2018，课题负责人

　　 中国药品招标中质量分层体系研究，R&D-based Pharmaceutical Association Committee (RDPAC), 03/2015-04/2016，课题负责人

　　 中国儿童用药研发参考数据库的构建及优化研究，科技部新药专项子课题，01/2014-12/2017，课题负责人

　　 广东省药招新政效果研究，广东医药价格协会，10/2014-12/2015，课题负责人

　　 基于药品监管能力的中国药品监管模式优化研究，国家社会科学基金面上项目，06/2013-12/2015，课题负责人

　　 中国药品监管绩效指标体系构建和评价研究，中国食品药品监督管理局, 04/2011-12/2013，课题负责人

　　 河北省基本药物政策实施效果评价研究，CMB(China Medical Board)，06/2011-12/2013，课题负责人

　　 中国药品监管绩效评价核心指标体系研究，中国食品药品监督管理局, 12/2009-04/2010，课题负责人

　　 中国药品监管现状（白皮书），中国食品药品监督管理局, 09/2007-07/2008，子课题负责人

　　 廉价短缺药品价格政策研究，国家发改委，03/2007-07/2008，课题负责人

Jiaxuan Yu, Song Yang, Bin Jiang. Framework and local experience of pharmaceutical reimbursement criteria policy (PRCP) in Chinat. Journal of Chinese Pharmaceutical Sciences, 2017,26(5),390-394

　　 Chan Chen, Bin Li,Dongsheng Yang,Bin Jiang.Implementation of NFS(2012) in Qingdao: from the perspective of public policy implementation.Journal of Chinese Pharmaceutical Sciences,2016,25(10),779-784,2016

　　 Menglu Qi,Bo Gao,FeiWang,Bin Jiang.Regulation of online pharmacies in China: the current situation and suggested improvement.Journal of Chinese Pharmaceutical Sciences, 2016, 25(9), 695-699,2016

　　 Xiaolin Zhu,Bin Li,Dongsheng Yang,Bin Jiang.Implementation strategy for eCTD electronic submission in China based on experiences from ICH countries.Journal of Chinese Pharmaceutical Sciences, 2016,25(7),552-558

　　 Lujia Chen, Guozhen Liu, Guo Huang, Dongsheng Yang, Bin Jiang. Institutional changes of China’s drug regulation and improvement solutions. Journal of Chinese Pharmaceutical Sciences, 2015, 24(12):821-825.

　　 Song Yang, Bin Jiang.Introduction to drug regulatory capabilities: a theory and framework. Journal of Chinese Pharmaceutical Sciences, 2015, 24 (4), 257–262

　　 Zhe Chen, Bin Jiang.Impact of GMP on pharmaceutical industry in China based on indicator system evaluation. Journal of Chinese Pharmaceutical Sciences, 2015, 24 (3), 185–191

　　 Zhao Yang, Yile Zhao, Jianwen Lan, Bin Jiang. Investigating on the effects of national essential medicine policy on primary care facilities in Hebei province: a case study. Journal of Chinese Pharmaceutical Sciences, 2015, 24(10):.683-689

　　 Xiaoyuan Zheng, Linguang Zhou, Bo Gao, Song Yang, Bin Jiang. Stakeholder analysis of clinical trials in China: a structural equation model, Journal of Chinese Pharmaceutical Sciences, 2015, 24(8):552-556

　　 10.Ming Quan,Song Yang, Yanyan Li,Zhixian Hou,BinJiang.Exploratory study on performance evaluation of drug administration at provincial level in China. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6) :503-507